Mustafa Yilmaz

Mustafa Yilmaz has a diverse work experience starting from their most recent position as a Medical Science Liaison and Associate Director at Rhythm Pharmaceuticals Inc. in 2022. Prior to this, they held the role of Medical Science Liaison and Senior Manager at the same company starting in 2019. Mustafa has also worked as a Regional Medical Liaison at Amgen in 2018. Mustafa Yilmaz has academic research experience, including being a Postdoctoral Researcher and Visiting Scientist at Harvard T.H. Chan School of Public Health in 2018 and a PhD student and Researcher at Harvard University from 2011 to 2018. Mustafa also has research experience as an MSc student and Researcher at Bilkent University from 2009 to 2011. Mustafa Yilmaz has additional research internships at MPI-CBG - Max Planck Institute of Molecular Cell Biology and Genetics, University of Gdansk, and Università degli Studi di Siena in 2008, 2007, and 2006 respectively.

Mustafa Yilmaz obtained a Doctor of Philosophy (Ph.D.) degree in Biology/Biological Sciences from Harvard University from 2011-2018. Prior to that, they earned a Master of Science (M.Sc.) degree in Molecular Biology and Genetics from Bilkent University from 2009-2011. Mustafa completed their undergraduate education at Bilkent University, where they received a Bachelor of Science (B.Sc.) degree in Molecular Biology and Genetics from 2005-2009.